Enzymatica Signs Loan Agreement With Major Shareholders

T-Reuters
16 Jun 2022

Enzymatica AB (publ) :Signs Loan Agreement With Major Shareholders.Has Signed A Two-Year Loan Agreement Of A Maximum Of 20 Msek With Its Three Largest Shareholders As Well As Chairman Of Board Bengt Baron And Ceo Claus Egstrand.Purpose Is To Support Company'S Liquidity In Periods Where Sales Are Lower Due To Seasonal Variations Or Remaining Effects Of Pandemic.Loan Agreement Has Been Signed On Market Terms (Stibor 3 Months + 7 % Incl. Fees) And Enzymatica Can Use All Or Part Of Amount According To Its Need.Utilized Loan Amount Should Be Repaid Starting 30 September 2024 And Be Fully Repaid On 30 March 2025 Latest.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10